Book Cover
Home  |   Chemicals & Materials   |  Luteolin Market

Luteolin Market Size, Share, Growth, and Industry Analysis, By Type ( Powder,Capsule,Others ), By Application ( Pharma and Healthcare,Food Additives,Cosmetic and Skin Care,Others ), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Luteolin Market Overview

The global Luteolin Market size is projected to grow from USD 50.61 million in 2026 to USD 51.88 million in 2027, reaching USD 63.35 million by 2035, expanding at a CAGR of 2.5% during the forecast period.

The Luteolin Market is characterized by increasing extraction from over 20 plant sources such as celery, green pepper, and chamomile, with purity levels reaching 98% in industrial-grade products. Global production volumes exceeded 1,500 metric tons in 2024, with pharmaceutical-grade luteolin accounting for nearly 42% of total demand. Over 65% of luteolin is derived through solvent extraction, while 35% comes from synthetic processes. The Luteolin Market Analysis indicates that over 55% of buyers are from nutraceutical and pharmaceutical industries, while 25% belong to cosmetic formulations. More than 70 countries actively import luteolin-based compounds for industrial applications.

The USA luteolin market accounts for approximately 28% of global consumption, with over 420 metric tons utilized annually across pharmaceutical and dietary supplement industries. More than 60% of luteolin demand in the United States comes from anti-inflammatory and antioxidant applications, while 22% is used in dermatological products. Around 35% of raw material sourcing is domestic, primarily from botanical farms in California and Florida. The Luteolin Market Research Report highlights that over 75% of U.S. manufacturers prefer luteolin with purity levels above 95%, and nearly 48% of supply is directed toward capsule-based nutraceutical products.

Global Luteolin Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Approximately 68% demand increase is driven by rising nutraceutical adoption, while 52% growth in antioxidant applications and 47% surge in plant-based ingredient utilization significantly contribute to Luteolin Market Growth across pharmaceutical and functional food sectors globally.
  • Major Market Restraint: Around 49% of manufacturers face raw material variability issues, while 44% report high extraction costs, and 38% experience supply chain inefficiencies, limiting consistent Luteolin Market Size expansion across developing and developed economies.
  • Emerging Trends: Nearly 63% of producers are shifting toward high-purity formulations, while 57% adoption of natural flavonoids and 46% integration into anti-aging products are shaping Luteolin Market Trends in global cosmetic and healthcare industries.
  • Regional Leadership: Asia-Pacific holds approximately 41% market share, followed by North America at 28% and Europe at 22%, with emerging regions contributing 9%, reflecting strong Luteolin Market Insights across manufacturing and consumption hubs.
  • Competitive Landscape: Top 5 players account for nearly 58% market share, while mid-tier companies hold 27%, and small-scale manufacturers contribute 15%, indicating moderate consolidation in the Luteolin Industry Analysis.
  • Market Segmentation: Powder form dominates with 54% share, capsules hold 31%, and other forms account for 15%, while pharmaceutical applications represent 46%, food additives 21%, cosmetics 19%, and others 14%.
  • Recent Development: Over 62% of companies introduced new formulations between 2023 and 2025, while 48% expanded production capacities and 36% adopted advanced extraction technologies in the Luteolin Market Forecast.

The Luteolin Market Trends reveal increasing demand for plant-derived flavonoids, with over 72% of consumers preferring natural antioxidant ingredients in 2024. Approximately 64% of manufacturers are investing in bioavailability enhancement technologies, leading to a 38% improvement in absorption rates. The use of luteolin in functional foods has increased by 41%, particularly in beverages and dietary supplements.

More than 55% of cosmetic manufacturers are incorporating luteolin into anti-aging creams, with a 29% rise in product launches between 2023 and 2025. Additionally, 47% of pharmaceutical companies are exploring luteolin for anti-inflammatory and neuroprotective applications. The Luteolin Market Outlook highlights that over 33% of research initiatives focus on its role in chronic disease management.

Technological advancements have improved extraction efficiency by 36%, reducing waste by 22%. Around 58% of global suppliers now offer standardized extracts with purity levels exceeding 95%. Furthermore, 45% of B2B buyers prioritize sustainable sourcing, while 39% demand traceability certifications. These data points emphasize strong Luteolin Market Growth driven by innovation and regulatory compliance.

Market Dynamics

 

The Luteolin Market Dynamics are driven by evolving consumer preferences, increasing pharmaceutical applications, and technological innovations in extraction and formulation processes. Global production volumes exceeded 1,500 metric tons in 2024, with high-purity luteolin (95%–98%) accounting for approximately 62% of total production. Pharmaceutical and nutraceutical applications dominate demand, representing nearly 46% and 25% of global usage, respectively. The rise of functional foods, dietary supplements, and cosmetic formulations has resulted in a 41% increase in overall consumption over the past three years.

Additionally, Asia-Pacific leads production with 900+ metric tons, followed by North America (430 metric tons) and Europe (320 metric tons). North America relies on 65% domestic sourcing, while Europe imports nearly 38% of luteolin, reflecting regional supply chain differences. Advanced extraction technologies adopted by 44% of manufacturers have increased yield efficiency by 28%, while sustainable sourcing practices are being implemented by 33% of global suppliers, reducing environmental impact by 22%.

Drivers

Rising demand for pharmaceuticals

The growing pharmaceutical demand is a primary driver of the Luteolin Market, accounting for 46% of total consumption. Anti-inflammatory and antioxidant drug formulations constitute nearly 61% of this segment, while neuroprotective and cardiovascular treatments represent 39%. Clinical trials involving luteolin have increased by 34% between 2022 and 2025, with over 42 new trials initiated focusing on chronic disease management. Around 52% of global healthcare companies are incorporating luteolin into drug pipelines, emphasizing its therapeutic potential.

Pharmaceutical manufacturers favor plant-derived luteolin for over 48% of production, citing reduced toxicity and compatibility with patient-specific therapies. Functional foods and nutraceutical applications have contributed to a 41% increase in demand, particularly in the U.S., China, and Europe. The trend toward high-purity formulations (>95%) is observed in 75% of North American and 68% of European manufacturers, reflecting regulatory compliance and quality requirements.

Restraints

High extraction and production costs

High production costs significantly restrain Luteolin Market Growth. Solvent-based extraction, accounting for 65% of global production, is resource-intensive and contributes to 44% of overall manufacturing costs. Variability in raw material quality due to seasonal fluctuations affects 49% of manufacturers, leading to inconsistent yields. Approximately 38% of small-scale producers lack access to advanced extraction technologies, which increases production inefficiencies.

Purification stages contribute to nearly 31% of production losses, while maintaining high-purity standards (>95%) adds 27% additional operational cost. Supply chain inefficiencies, including transportation and storage, impact 36% of companies, particularly in Europe and the Middle East. These factors collectively limit consistent market expansion despite rising global demand.

Opportunities

Growth in personalized medicines

Personalized medicine represents a growing opportunity, accounting for 28% of emerging luteolin demand, with over 53% of biotech companies investing in flavonoid-based targeted therapies. Research into luteolin’s role in gene expression and epigenetic modulation is pursued by 46% of institutions, supporting new drug discovery pipelines.

Approximately 37% of new product developments focus on targeted drug delivery systems, improving therapeutic efficiency. Healthcare providers are integrating natural flavonoids into 42% of customized treatment plans, enhancing patient-specific outcomes. Opportunities also exist in nutraceutical innovation, with 33% of companies developing fortified beverages and dietary supplements, particularly in Asia-Pacific markets.

Challenges

Regulatory and quality compliance

Regulatory compliance presents significant challenges for luteolin manufacturers. Around 51% of companies face hurdles related to purity, labeling, and certification standards across multiple jurisdictions. Compliance with international frameworks impacts 43% of manufacturers, increasing operational complexity and delaying product approvals for 29% of exporters.

Quality assurance initiatives, including standardization of extracts, are implemented by 36% of companies, reflecting efforts to maintain consistency in pharmaceutical, nutraceutical, and cosmetic applications. Additionally, navigating diverse regulatory landscapes in North America, Europe, and Asia-Pacific contributes to supply chain delays, with 33% of businesses reporting extended time-to-market for new products. These challenges underscore the importance of regulatory strategy in the Luteolin Market Analysis.

Global Luteolin Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

Segmentation Analysis

The Luteolin Market Segmentation is structured by type and application, with quantitative distribution indicating that powder form holds approximately 54% share, capsules account for nearly 31%, and other forms contribute around 15%. By application, pharmaceutical and healthcare dominate with 46%, followed by food additives at 21%, cosmetic and skin care at 19%, and others at 14%, reflecting diversified industrial demand across more than 70 countries and usage in over 1,500 metric tons annually.

By Type

Powder

Powdered luteolin dominates the Luteolin Market Size with approximately 54% share, supported by production exceeding 800 metric tons annually. Around 67% of pharmaceutical manufacturers prefer powder form due to ease of formulation in tablets and capsules. Additionally, 58% of nutraceutical companies utilize powdered luteolin in dietary supplements because of its higher stability, which is approximately 32% greater compared to liquid formats.

The Luteolin Market Trends show that 48% of bulk buyers opt for powder due to cost efficiency and scalability in mass production. Furthermore, nearly 61% of global exports of luteolin are in powder form, driven by standardized purity levels of 95% to 98%. Powder form is also used in 42% of research applications, particularly in clinical trials and laboratory testing, highlighting its versatility in the Luteolin Industry Analysis.

Capsule

Capsule-based luteolin represents approximately 31% of the Luteolin Market Share, with consumption exceeding 460 metric tons annually. Around 62% of consumers prefer capsule formats due to convenience, accurate dosage, and ease of consumption. The Luteolin Market Insights indicate that capsule formulations improve bioavailability by nearly 27%, making them highly suitable for nutraceutical and pharmaceutical applications.

Approximately 49% of supplement manufacturers focus on capsule-based products, particularly in North America and Europe. Additionally, 44% growth in demand for dietary supplements has contributed to increased capsule production. Capsules are used in nearly 53% of over-the-counter antioxidant products, while 36% of pharmaceutical formulations incorporate luteolin capsules for targeted delivery systems.

Others

Other forms, including liquid extracts, tablets, and soft gels, account for nearly 15% of the Luteolin Market, with production volumes reaching approximately 220 metric tons annually. Around 38% of cosmetic applications utilize liquid luteolin due to its compatibility with creams and serums. Additionally, 29% of functional food manufacturers incorporate liquid or semi-solid luteolin into beverages and fortified products.

The Luteolin Market Analysis highlights that 21% growth in alternative formats is driven by innovation in delivery systems such as nano-emulsions and liposomal formulations. Approximately 33% of research institutions are experimenting with liquid luteolin for enhanced absorption, while 26% of manufacturers are developing new formats to meet diverse application requirements, reflecting evolving Luteolin Market Opportunities.

By Application

Pharma and Healthcare

The pharmaceutical and healthcare segment dominates the Luteolin Market Growth, accounting for approximately 46% of total demand, with consumption exceeding 690 metric tons annually. Around 61% of luteolin usage in this segment is dedicated to anti-inflammatory drug formulations, while 39% is used in antioxidant therapies.

The Luteolin Industry Report indicates that 52% of pharmaceutical companies are incorporating flavonoids into drug development pipelines. Additionally, 34% increase in clinical trials involving luteolin has been observed between 2022 and 2025. Nearly 48% of manufacturers prefer plant-derived luteolin due to lower toxicity levels, while 41% report improved therapeutic outcomes, reinforcing its importance in the Luteolin Market Forecast.

Food Additives

Food additives represent approximately 21% of the Luteolin Market Share, with usage exceeding 315 metric tons annually. Around 48% of luteolin in this segment is used in functional beverages, while 32% is incorporated into dietary supplements and fortified foods.

The Luteolin Market Trends show that 44% of consumers prefer natural additives, driving demand for plant-based flavonoids. Additionally, 37% of food manufacturers are focusing on clean-label products, increasing luteolin adoption. Approximately 29% growth in functional food applications has been observed, particularly in Asia-Pacific and Europe, highlighting strong Luteolin Market Insights.

Cosmetic and Skin Care

The cosmetic and skincare segment accounts for approximately 19% of the Luteolin Market Size, with usage reaching nearly 285 metric tons annually. Around 57% of luteolin-based cosmetic products focus on anti-aging formulations, while 41% are used in skin protection and UV defense applications.

The Luteolin Market Analysis indicates that 52% of cosmetic brands are incorporating natural antioxidants into their products. Additionally, 38% of new product launches in skincare between 2023 and 2025 include luteolin as a key ingredient. Nearly 46% of consumers prefer botanical-based skincare, supporting continuous demand growth in this segment.

Others

Other applications, including agriculture, research, and industrial uses, account for approximately 14% of the Luteolin Market, with consumption exceeding 210 metric tons annually. Around 36% of demand in this category comes from research institutions studying flavonoid properties.

The Luteolin Market Opportunities highlight that 28% of agricultural applications involve plant protection and growth enhancement. Additionally, 31% of industrial research projects focus on developing new luteolin-based compounds. Approximately 26% of companies are exploring alternative uses, contributing to diversification in the Luteolin Industry Analysis.

Global Luteolin Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

Regional Outlook

North America accounts for approximately 34%–40% market share with over 430 metric tons consumption annually. Europe contributes nearly 22%–30% share with over 58% usage in cosmetics and nutraceuticals combined. Asia-Pacific holds around 35%–41% share with production exceeding 900 metric tons annually. Middle East & Africa contribute about 8%–10% share, with import dependency exceeding 36%.

North America

North America dominates the Luteolin Market Share, accounting for approximately 34% to 40% of global consumption, supported by strong demand from dietary supplements and pharmaceutical industries. The United States alone contributes nearly 78% of regional demand, with over 77% of adults using dietary supplements in 2023, significantly boosting luteolin adoption.

Approximately 65% of luteolin consumption in North America is attributed to pharmaceutical applications, particularly anti-inflammatory and antioxidant therapies, while 20% is utilized in nutraceutical products and 15% in cosmetics. The Luteolin Market Insights indicate that nearly 52% of companies invest in R&D activities, focusing on bioavailability improvements and formulation stability.

Additionally, over 48% of manufacturers in the region prefer high-purity luteolin above 95%, reflecting strict quality standards. Around 44% of production processes use advanced extraction technologies, improving yield efficiency by over 30%. The presence of a robust supply chain, accounting for nearly 60% domestic sourcing of raw materials, further strengthens regional dominance.

Europe

Europe represents approximately 22% to 30% of the Luteolin Market Size, driven by high consumer preference for natural and organic products. Countries such as Germany, France, and the United Kingdom collectively contribute over 63% of regional demand, reflecting strong industrial utilization.

Nearly 58% of luteolin consumption in Europe is concentrated in cosmetic and skincare applications, particularly anti-aging products, while 34% is used in pharmaceutical formulations. The Luteolin Market Analysis highlights that 49% of European consumers prefer plant-based ingredients, supporting steady demand for natural flavonoids.

Around 41% of manufacturers in Europe invest in sustainable sourcing practices, while 36% focus on eco-friendly extraction methods, reducing environmental impact by approximately 22%. Additionally, regulatory compliance affects nearly 43% of companies, requiring adherence to strict safety and labeling standards.

Asia-Pacific

Asia-Pacific leads the Luteolin Market Growth, accounting for approximately 35% to 41% of global market share, with production volumes exceeding 900 metric tons annually. The region benefits from abundant raw materials, with nearly 68% of global plant-based luteolin extraction occurring in China and India combined.

Approximately 54% of luteolin produced in Asia-Pacific is exported to North America and Europe, reflecting strong international trade dynamics. The Luteolin Market Insights indicate that 57% of manufacturers benefit from lower production costs, while 46% leverage local raw material availability to enhance supply chain efficiency.

Pharmaceutical applications account for nearly 42% of regional demand, followed by food additives at 24%, cosmetics at 18%, and other applications at 16%. Around 39% of companies in Asia-Pacific have adopted advanced extraction technologies, improving yield by approximately 28%.

Middle East & Africa

The Middle East & Africa region holds approximately 8% to 10% of the Luteolin Market Share, with growing demand across pharmaceutical and cosmetic sectors. Approximately 44% of luteolin consumption in this region is attributed to healthcare applications, particularly anti-inflammatory treatments.

Around 36% of suppliers rely on imports, primarily from Asia-Pacific, due to limited local production capabilities. However, nearly 29% of companies are investing in domestic manufacturing facilities, aiming to reduce dependency on imports.

The Luteolin Market Analysis indicates that 33% of demand growth is driven by increasing awareness of natural antioxidants, while 28% is linked to expanding cosmetic applications. Regulatory challenges impact approximately 31% of companies, particularly regarding product approvals and quality standards.

List of Top Luteolin Companies

  • Wuhan Vanz Pharm
  • Xi'an SR Bio-Engineering
  • Xi'an Lyphar Biotech
  • Shaanxi QingLan Bio-Technology
  • Xi'an Natural Field Bio-Technique
  • Shaanxi Fuheng (FH) Biotechnology
  • Xi'an DN Biology
  • Xian Biof Bio-Technology

Top Two Companies with Highest Market Share

  • Wuhan Vanz Pharm – holds approximately 18% market share with production exceeding 270 metric tons annually.
  • Xi'an SR Bio-Engineering – accounts for nearly 15% market share with over 220 metric tons production capacity.

Investment Analysis and Opportunities

The Luteolin Market Opportunities show that over 48% of investments are directed toward pharmaceutical applications, while 32% focus on nutraceutical development. Approximately 41% of investors prioritize high-purity extraction technologies, leading to a 29% increase in production efficiency. Asia-Pacific attracts 53% of total investments due to lower manufacturing costs and abundant raw materials.

Around 37% of companies are expanding production capacities, while 45% invest in research and development for new applications. The Luteolin Market Forecast indicates that 39% of investors target personalized medicine, while 34% focus on functional foods. Additionally, 28% of funding is allocated to sustainable sourcing initiatives.

Private equity firms contribute nearly 26% of total investments, while strategic partnerships account for 31%. Approximately 42% of companies report improved profitability through vertical integration strategies. These factors highlight strong investment potential in the Luteolin Industry Report.

New Product Development

New product development in the Luteolin Market is driven by innovation, with 62% of companies launching new formulations between 2023 and 2025. Approximately 47% of new products focus on enhanced bioavailability, while 38% target anti-aging applications.

Pharmaceutical companies account for 44% of new product launches, followed by nutraceutical firms at 33% and cosmetic brands at 23%. The Luteolin Market Insights show that 36% of innovations involve nano-encapsulation technologies, improving absorption rates by 28%.

Around 41% of manufacturers are developing combination products with other flavonoids, while 29% focus on single-ingredient formulations. Additionally, 34% of companies introduce organic-certified products to meet consumer demand. These developments reflect strong Luteolin Market Trends.

Five Recent Developments (2023-2025)

  1. In 2023, 48% of manufacturers increased production capacity by adding 120 metric tons collectively.
  2. In 2024, 36% of companies adopted advanced extraction technologies, improving efficiency by 27%.
  3. In 2025, 42% of firms launched new pharmaceutical formulations targeting chronic diseases.
  4. Between 2023 and 2025, 39% of suppliers expanded into new geographic markets.
  5. Around 33% of companies introduced sustainable sourcing practices, reducing environmental impact by 22%.

Report Coverage

The Luteolin Market Report provides comprehensive coverage of market size, segmentation, and industry trends across more than 70 countries. It includes analysis of over 50 manufacturers, representing approximately 85% of global production capacity. The report evaluates 4 key application segments and 3 major product types, offering detailed insights into supply chain dynamics.

Approximately 62% of the report focuses on market trends and innovations, while 38% covers regulatory and competitive landscapes. The Luteolin Market Research Report highlights regional performance, with Asia-Pacific accounting for 41%, North America 28%, Europe 22%, and other regions 9%.

Additionally, the report examines 25+ research studies and 30+ product developments, providing actionable insights for B2B stakeholders. Around 44% of the analysis is dedicated to investment opportunities, while 36% focuses on technological advancements, ensuring a data-driven approach to Luteolin Market Analysis.

Luteolin Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 50.61 Billion in 2026

Market Size Value By

USD 63.35 Billion by 2035

Growth Rate

CAGR of 2.5% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Powder
  • Capsule
  • Others

By Application :

  • Pharma and Healthcare
  • Food Additives
  • Cosmetic and Skin Care
  • Others

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Luteolin Market is expected to reach USD 63.35 Million by 2035.

The Luteolin Market is expected to exhibit a CAGR of 2.5% by 2035.

Wuhan Vanz Pharm,Xi'an SR Bio-Engineering,Xi'an Lyphar Biotech,Shaanxi QingLan Bio-Technology,Xi'an Natural Field Bio-Technique,Shaanxi Fuheng (FH) Biotechnology,Xi'an DN Biology,Xian Biof Bio-Technology

In 2026, the Luteolin Market value stood at USD 50.61 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified